It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The ventral pallidum (VP) contains GABA and glutamate neurons projecting to ventral tegmental area (VTA) whose stimulation drives approach and avoidance, respectively. Yet little is known about the mechanisms by which VP cell types shape VTA activity and drive behavior. Here, we found that both VP GABA and glutamate neurons were activated during approach to reward or by delivery of an aversive stimulus. Stimulation of VP GABA neurons inhibited VTA GABA, but activated dopamine and glutamate neurons. Remarkably, stimulation-evoked activation was behavior-contingent such that VTA recruitment was inhibited when evoked by the subject’s own action. Conversely, VP glutamate neurons activated VTA GABA, as well as dopamine and glutamate neurons, despite driving aversion. However, VP glutamate neurons evoked dopamine in aversion-associated ventromedial nucleus accumbens (NAc), but reduced dopamine release in reward-associated dorsomedial NAc. These findings show how heterogeneous VP projections to VTA can be engaged to shape approach and avoidance behaviors.
Ventral pallidum GABA and glutamate neuron activation drives approach and avoidance, respectively. Here, the authors show that both ventral pallidum cell types are activated during approach to reward and by aversive stimuli, but elicit opponent effects on VTA cell-type activity.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 University of California San Diego, Department of Neurosciences, La Jolla, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242); Veterans Affairs San Diego Healthcare System, Research Service, San Diego, USA (GRID:grid.410371.0) (ISNI:0000 0004 0419 2708)
2 University of California San Diego, Department of Neurosciences, La Jolla, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242)
3 San Diego, Department of Psychiatry, University of California, La Jolla, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242)
4 Veterans Affairs San Diego Healthcare System, Research Service, San Diego, USA (GRID:grid.410371.0) (ISNI:0000 0004 0419 2708); San Diego, Department of Psychiatry, University of California, La Jolla, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242)